On the Couch

In this episode of On the Couch , Henry Jennings speaks with Dr Andreas Fouras , Managing Director and CEO of 4DMedical (ASX: 4DX). Many Marcus Today members will know 4DX from when it was a fraction of its current price. Henry has long been a fan of the company, which has developed XV Technology – a proprietary software platform enabling non-invasive, quantitative imaging and analysis of lung fun...

In this episode of On the Couch , Henry Jennings speaks with Igor Pejic , author of Tech Money – a new book on the rules of investing in the technology age. They cover why tech investing requires a different playbook, the AI bubble debate, which industries face the biggest disruption, and what quantum computing could mean for the decade ahead. — Marcus Today – Daily Market Insights Marcus Today pr...

In this episode of On the Couch , Henry Jennings speaks with Jonathon Higgins from Unified Capital Partners. They cover the state of ASX tech, the AI trade in the US, and the emerging neocloud sector – including the Australian players worth watching and where the real money is flowing inside the data centre boom. — Marcus Today – Daily Market Insights Marcus Today provides clear, practical comment...

In this episode of On the Couch , Henry Jennings sits down with Alex Pollak , founder and CIO of Loftus Peak. They cover the AI investment landscape, where the real opportunities are in the current market, and why Loftus Peak is increasingly looking beyond pure tech – into China, biotech, and energy storage. — Marcus Today – Daily Market Insights Marcus Today provides clear, practical commentary f...

In this episode of On the Couch , Henry Jennings speaks with Dr Liz Dallimore , CEO of Argenica Therapeutics (ASX: AGN). Fresh from presenting phase two trial data at a major international stroke conference, Liz walks through what the results showed, why neuroprotection is such a difficult space, and what the path forward looks like for the company. — Marcus Today – Daily Market Insights Marcus To...

In this episode of On the Couch , Henry Jennings speaks with Jon Pilcher , CEO of Neuren Pharmaceuticals (ASX: NEU), on his fourth appearance on the podcast. They cover the European regulatory setback, strong US sales momentum, and what the phase three trial for Neuren's second drug candidate means for the company's outlook. — Marcus Today – Daily Market Insights Marcus Today provides cl...

Welcome to the latest episode of On the Couch with Marcus Today's Henry Jennings. This episode, Henry sits down with Nick Griffin – founding partner and CIO of Munro Partners. Nick has been on the couch before, and it's a timely catch-up in what has been an 'interesting' market. Full disclosure: Henry is a shareholder of MAET. Nick brings over 25 years of financial services exp...

VIDEO AVAILABLE: https://vimeo.com/1181449274 Chris Stott (1851 Capital) joins Callum Newman to break down the current small-cap landscape – and why the next six months may be more difficult than many expect. In this discussion, Chris outlines how rising interest rates, geopolitical volatility and shifting investor sentiment are shaping opportunities in Australian equities. Despite near-term cauti...

In this episode of On the Couch , Henry Jennings speaks with Coby Hanoch , CEO of Weebit Nano (ASX: WBT), about the surge in memory demand driven by AI. They discuss the difference between embedded and discrete memory, recent commercial progress, and where ReRAM fits in the next phase of semiconductor growth. A clear look at what is driving the sector – and what comes next. — Marcus Today – Daily...

Welcome to the latest episode of On the Couch with Henry Jennings from Marcus Today. In this episode, Henry is joined by his old friend Richard Morrow from Lowell Resources Trust (ASX: LRT). They discuss all things gold – why he still likes the sector and which stocks he recommends. Richard is the former Chair of the Melbourne Mining Club and a director of LRT. A great look at the gold sector from...

Prefer to watch? Check out the full interview on video here: VIDEO – On the Couch with Gary Norden: Inside a 35-Year Trading Career A bit of a different approach at Marcus Today; Callum Newman sits down with Gary Norden, a 35+ year pro trader (LIFFE floor, bank derivatives desks, hedge funds) and the author of An End to the Bull – to talk how the pros actually trade when it's their own money...

Welcome to another episode of On the Couch , the podcast series where we chat with brokers, CEOs, and fund managers to bring you valuable insights from the investing world. In this quickie episode, Henry Jennings is joined by his good friend Andrew Wielandt – also known as The ETF Whisperer . Andrew shares his ETF picks for the year ahead… and not a QUAL in sight. Chapter Markers 0:00 – Welcome An...

Welcome to another episode of On the Couch . In this episode, Henry Jennings catches up with Scott Kirkland from EMVision Medical Devices (ASX: EMV). Scott is the co-founder of EMVision Medical Devices Ltd and has held several senior sales roles, including Head of Client Sales at US-based technology company Quantcast, before founding Kirkland Capital to focus on emerging technologies. At EMVision,...

Welcome to the latest episode of On the Couch . In this episode, Henry Jennings from Marcus Today sits down with Nathan Smith , CEO of Neuroscientific Biopharmaceuticals, to unpack how a differentiated mesenchymal stem cell therapy is progressing from acquisition to patient impact in refractory Crohn's disease. With promising real-world data via special access programs, a clear regulatory pat...

Welcome to the latest episode of On the Couch . In this episode, Henry Jennings sits down with trading mentor and author Louise Bedford – always a popular guest, known for her valuable insights into markets and trading mentality. Louise shares her approach to selling, the importance of discipline, and breaks down what sectors are currently hot – and which ones are ice cold. She is a behavioural fi...

Welcome to the latest episode of On the Couch . In this episode, Henry Jennings is joined by Jonathon Higgins from Unified Capital Partners. A frequent guest on the podcast, Jonathon needs no introduction. He is Head of Research at boutique broker UCP and, as always, brings some great stock selections to the table. — Marcus Today – Daily Market Insights Marcus Today provides clear, practical comme...

Welcome to the latest episode of On the Couch . In this episode, Henry Jennings sits down with Armina Rosenberg , co-founder of funds management group Minotaur Capital. Armina represents a new breed of 'rock star' fund manager – one harnessing the power of AI to build a fund unlike any other. From a childhood in Western Sydney to running global equities for the Atlassian founders, Armina...

Welcome to this Christmas episode of On the Couch . In this special edition, Henry Jennings sits down with Adam Dawes from Shaw and Partners to reflect on what investors have learned from 2025 – and, more importantly, what themes and stocks are worth watching in 2026. Adam is a long-time friend of the podcast and a regular guest across major media outlets, known for his experience, insights, and p...

Welcome to the latest episode of On the Couch . In this episode, Henry Jennings is joined by Dr Francis Wedin , Chair of Vulcan Energy (ASX: VUL). A long-time friend of the podcast, Francis founded Vulcan around seven years ago. He was previously Executive Director of ASX-listed Exore Resources, where he successfully developed two new lithium resources across two continents. Vulcan Energy has rece...

Welcome to the latest episode of On the Couch . In this episode, Henry Jennings is joined by Jon Pilcher , CEO of Neuren Pharmaceuticals (ASX: NEU). The pair first spoke around three years ago, and with Neuren delivering impressive results for investors since then, it felt like the perfect time for a catch-up – especially with 2026 shaping up to be another pivotal year. Jon joined Neuren in 2013 a...

Welcome to the latest episode of On the Couch . In this episode, Henry Jennings sits down with Trade View Founder, Robert Bubalovski , to talk all things algo and AI in trading. Robert founded Trade View 14 years ago with the goal of helping traders build their own models and systems – giving them the tools to harness algorithms, develop strategies, and take emotion out of the equation. He's...

Welcome to the latest episode of On the Couch . In this episode, Henry Jennings sits down with trading mentor and author Louise Bedford – always a popular guest, offering valuable insights into markets and trading mentality. Louise is a behavioural finance expert, bestselling author, and seasoned trader with over 30 years of experience. She hosts the Talking Trading podcast and is widely regarded...

Welcome to the latest episode of On the Couch . In this episode, Henry Jennings is joined by his good friend and long-time market guru Jonathon Higgins from Unified Capital Partners – along with Jonathon's colleague, James Bisinella , Senior Equities Research Analyst at UCP in Melbourne. Most listeners will already be familiar with Jonathon's valuable contributions over the years, and Ja...

Welcome to the latest episode of On the Couch . In this episode, Henry Jennings chats with Dr Mark Bennett , Non-Executive Chair at Falcon Metals (ASX: FAL). Dr Bennett is a highly experienced geologist and mining executive with over 30 years' experience in gold and base metal exploration. He was the founding Managing Director and CEO of Sirius Resources (ASX: SIR), where he received the AMEC...

Welcome to the latest episode of On the Couch . In this episode, Henry Jennings catches up with Jim Corbett from Avita Medical (ASX: AVH). Jim was appointed CEO of AVITA Medical in September 2022, after serving on the Board since June 2021. He brings nearly 40 years of leadership experience in the medical device field, most recently as CEO of CathWorks Ltd., a software-based medical technology com...